鼻カニューレの世界市場-2022-2029

市場概要

鼻カニューレの世界市場規模は、2022年に63億8,761万米ドル、2029年には100億8,539万米ドルに達すると推定され、予測期間（2022～2029年）においてCAGR5.84%で成長するとされています。

鼻カニューレは、呼吸器疾患の患者さんに高気流または補助酸素を供給する医療機器です。このデバイスは、酸素供給を改善し、より良い換気を提供します。一端が2つの突起に分かれたチューブで構成され、そこから酸素が流れます。

市場力学

鼻カニューレの世界市場を牽引する主な要因は、喘息、COPD、肺炎などの呼吸器疾患の発生率増加による鼻カニューレの需要増、技術的進歩、新製品の上市などです。

研究開発投資の増加や新たな技術的進歩は、市場の成長を促進するものと期待されています。

鼻カニューレ市場は、技術の進歩の高まり、老年人口の増加、研究開発投資の急増、喘息やCOPDなどの呼吸器疾患の増加、新興国市場の医療インフラの改善とともに最新技術を用いた新規製品の改良によって牽引されています。

鼻カニューレは、呼吸器疾患の患者さんに酸素を補給するために使用されます。COVIDにより、政府は鼻カニューレなど必要な製品の需要を満たすために、さまざまなファンドやイニシアチブを開始しました。これらの資金は、すべての必須ヘルスケア製品の生産に役立てられます。呼吸器系疾患の増加により、これらのアプリケーションの市場は世界的に拡大しています。さらに、主要企業による技術的に高度な製品の提供も、市場の成長に重要な役割を果たすと予想されます。

様々な新規製品の発売や調査研究は、市場の成長に寄与しています。例えば、2022年5月、急性および慢性呼吸器ケアおよび製品を提供するFisher &Paykel Healthcare Corporationは、Airvo 3 high-flow systemの発売を発表しました。このデバイスは、Optiflow療法を提供するAirvo 2よりも高度な技術を提供します。ターゲットを絞った酸素供給には、正確な酸素濃度を提供するOptiO2クローズドループシステムを搭載しています。また、内蔵バッテリーと大型タッチスクリーンインターフェースもこの最新システムに搭載されています。

鼻カニューレに関連する副作用が市場成長の妨げになると予想されます。

喉の乾燥、鼻の乾燥、目の刺激、胃拡張、マスクの不快感、鼻や目の外傷、時には鼻血など、鼻カニューレ使用後のさまざまな副作用は、鼻カニューレ市場の成長を妨げる大きな要因となっています。

長期的な補助酸素の使用は、高圧の蓄積により肺や目に損傷を与える肺酸素中毒により、目の損傷や肺の損傷を引き起こす可能性があります。さらに、中枢神経系に高圧が蓄積することで健忘症などの重篤な合併症を引き起こし、複数の臓器に影響を及ぼす可能性もあります。厳しい規制も市場の成長を阻害する重要な要因となっています。

COVID-19の影響分析

パンデミックは、世界の金融への期待、業務、危機対応戦略にプラスの影響を与えています。COVID-19の発生は、ヘルスケア産業に深刻な影響を与えました。鼻カニューレ市場は、これらの鼻カニューレの需要につながるウイルスのために呼吸器疾患の発生率が増加したため、COVIDによって巨額の利益を経験しました。主要メーカーは、様々な研究や臨床試験を開始しました。様々なイニシアチブ、製品の発売、コラボレーションや合併は、市場の成長を後押しし、世界中で起こっています。例えば、2022年11月、Hamilton Medicalは、HAMILTON-C3 Ventilatorが換気または高流量酸素療法を切り替えられると発表しました。HAMILTON-C3は、60リットル/分の流量を提供します。換気のモードと患者のインターフェースのみを変更する必要があります。

目次

第1章 調査手法と調査範囲

• 調査手法
• 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 市場影響要因
  • 促進要因
    • 研究開発投資の増加
    • 技術的進歩の高まり
  • 抑制要因
    • 鼻カニューレに関連する副作用
  • ビジネスチャンス
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• プライシング分析
• 規制分析

第6章 COVID-19の分析

• COVID-19の市場分析
  • COVID-19以前の市場シナリオ
  • COVID-19の現在の市場シナリオ
  • COVID-19の後、または将来のシナリオ
• COVID-19の中での価格ダイナミクス
• 需要-供給スペクトラム
• パンデミック時の市場に関連する政府の取り組み
• メーカーの戦略的取り組み
• まとめ

第7章 タイプ別

• 高流量鼻カニューレ
• 低流量鼻カニューレ

第8章 プロング形状別

• カーブド＆フレアープロング
• カーブドプロング
• フレアープロング
• ストレートプロング

第9章 素材別

• PVC
• シリコーン
• その他

第10章 用途別

• 気管支喘息
• 慢性閉塞性肺疾患
• 嚢胞性線維症
• 睡眠時無呼吸症候群
• 肺炎
• 心臓血管外科
• 糖尿病治療
• その他

第11章 エンドユーザー別

• 病院
• 外来手術センター
• 新生児集中治療室
• 在宅医療
• その他

第12章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第13章 競合情勢

• 主な展開と戦略
• 企業シェア分析
• 製品ベンチマーク
• 注目の主要企業リスト

第14章 企業プロファイル

• Smith's Medical（ICU Medical）
  • 企業概要
  • 製品ポートフォリオと説明
  • 主なハイライト
  • 財務概要
• Teleflex Inc.
• Medline Industries Inc.
• Hamilton Medicals
• Neotech Products
• Medin Medical Innovations GmbH
• Flexicare Ltd.
• Fairmont Medical
• Fisher & Paykel Healthcare Limited
• Sunset Healthcare Solutions Inc.

第15章 鼻カニューレの世界市場-DataM

Market Overview

The global nasal cannula market size was valued at US$ 6,387.61 million in 2022 and is estimated to reach US$ 10,085.39 million by 2029, growing at a CAGR of 5.84% during the forecast period (2022-2029).

The nasal cannula is a medical device that provides high airflow or supplemental oxygen to patients with respiratory disorders. This device improves oxygenation and provides better ventilation. It consists of a tube that splits into two prongs at one end from which the oxygen flows.

Market Dynamics

The major factors driving the global nasal cannula market are the rising demand for nasal cannulas owing to increasing incidences of respiratory disorders such as asthma, COPD, and pneumonia, technological advancements and novel product launches.

The increasing research and development investments and novel technological advancements are expected to drive the market's growth.

The nasal cannula market is driven by rising advancements in technology, an increase in the geriatric population, a surge in research and development investments, an increasing number of respiratory disorders such as asthma and COPD, and improvements in novel products using the latest technology along with improvements in medical infrastructure in emerging markets.

The nasal cannula is used for providing supplemental oxygen to breathing disorder patients. Due to COVID, the government started various funds and initiatives to meet the demand for the required product, such as a nasal cannula. These funds will help in the production of all essential healthcare products. The market for these applications is increasing worldwide due to the enhanced number of respiratory disorders. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market's growth.

Various novel product launches and research studies contribute to the market's growth. For instance, in May 2022, Fisher & Paykel Healthcare Corporation, an acute and chronic respiratory care and products provider, announced its Airvo 3 high-flow system's release. This device provides more advanced technology than Airvo 2, which delivers Optiflow therapy. For targeted oxygen delivery, it has an OptiO2 closed-loop system that delivers an accurate oxygen level. An integrated battery and a large touchscreen interface are also included in this latest system.

Side effects associated with nasal cannulas are expected to hamper the market's growth.

Various side effects after using nasal cannulas, such as dry throat, nasal dryness, eye irritation, gastric distension, mask discomfort, nasal and eye trauma and sometimes bleeding nose, are the major factor hindering the growth of the nasal cannula market.

Long-term supplemental oxygen usage may result in eye damage or lung damage due to pulmonary oxygen toxicity, a condition in which high-pressure build-up causes damage to the lungs or eyes. It can even cause severe complications such as amnesia due to high-pressure build-up in the CNS and can affect multiple organs. Stringent regulations are also a key factor hindering the growth of the market.

COVID-19 Impact Analysis

The pandemic has positively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The nasal cannula market has experienced huge profits due to COVID, as the incidence of respiratory disorders increased due to the virus leading to demand these nasal cannulas. Key manufacturers have started various research and clinical trials. Various initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Nov 2022, Hamilton Medical announced that its HAMILTON-C3 Ventilator could be switched between ventilation or high-flow oxygen therapy. HAMILTON-C3 provides 60 liters/minute flow rate. Only the mode of ventilation and patient interface is needed to be changed.

Segment Analysis

The high-flow nasal cannula-type segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The type segment is the highest market holder in the global nasal cannula market. The global nasal cannula market is segmented based on type as a high-flow nasal cannula and low-flow nasal cannula. The high-flow nasal cannula segment is the largest market shareholder due to its inherent advantages over low-flow cannulas, increasing technological advancements and novel product launches.

The high-flow nasal cannula is a non-invasive respiratory help. This oxygen system delivers around 100% heated and humidified oxygen at approximately 60 liters per minute flow rate. The high-flow cannulas settings are independent and provide better outcomes and high confidence and control when used in supplemental oxygen delivery. High-flow nasal cannulas have various benefits, as humidified and heated oxygen decreases airway inflammation and energy expenditure.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, in May 2022, Fisher & Paykel Healthcare Corporation Limited, an acute and chronic respiratory care products provider, announced the launch of its products Optiflow Switch and Optiflow Trace, two latest nasal high-flow interfaces specially designed for applications in anesthesia. These will expand Optiflow nasal high-flow's market opportunity within the company's respiratory segment. The optiflow Switch interface is developed for anesthesia and provides high-humidified oxygen flow. The Optiflow Trace interface is used for the sedation procedure that provides high humidified oxygen flow and samples the expired CO2.

Geographical Analysis

North America holds the largest market share in the global nasal cannula market.

North America dominates the global nasal cannula market primarily due to its large population, excellent medical infrastructure, and high-income levels. The market is expected to grow at a relatively moderate pace during the forecast period due to healthcare expenditure in the US. The market's significant size is attributed to the high medical expenditure.

Increasing expenditure on healthcare and raising awareness among people are also contributing to the market's growth in this region. Advancement of applications of the nasal cannula in several respiratory diseases or surgical procedures, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the nasal cannula market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in Dec 2021, Sunset Healthcare Solutions, a respiratory and medical equipment supplier, announced its partnership with Vizient Supply LLC.

Competitive Landscape

The nasal cannula market is moderately competitive with local and global companies' presence. Smith's Medical (ICU Medical), Teleflex Inc., Medline Industries Inc., Hamilton Medicals, Neotech Products, Medin Medical Innovations GmbH, Flexicare Ltd., Fairmont Medical, Fisher & Paykel Healthcare Limited, Sunset Healthcare Solutions Inc. and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in October 2022, Medline announced its multi-year vendor partnership with Hoag Memorial Hospital Presbyterian health system to provide essential medical supplies portfolio to the acute and non-acute care network.

Smith's Medical (ICU Medical).

Overview: Smith's Medical, now a part of ICU Medical, is a developer and manufacturer of innovative medical products used in vital care applications. Established in 1940 and is headquartered in Minnesota, United States.

Product Portfolio:

Portex First Breath: This nasal cannula provides O2 in low and medium concentrations, with flared or non-flared tips. It can be used for adults, neonatal, as well as pediatrics.

Key Development: In Jan 2022, ICU Medical Inc. announced its acquisition of Smith's Medical. Adding vital care products to the ICU portfolio.

The global nasal cannula market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing research and development investments
    • 4.1.1.2. Rising technological advancements
  • 4.1.2. Restraints:
    • 4.1.2.1. Side effects associated with nasal cannula
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1 Porter's Five Forces Analysis
• 5.2 Supply Chain Analysis
• 5.3 Pricing Analysis
• 5.4 Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturer's Strategic Initiatives
• 6.6. Conclusion

7. By Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 7.1.2. Market Attractiveness Index, By Type
• 7.2. High Flow Nasal Cannula*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 7.3. Low Flow Nasal Cannula

8. By Prong Shape

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Prong Shape
  • 8.1.2. Market Attractiveness Index, By Prong Shape
• 8.2. Curved and Flared Prongs *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 8.3. Curved Prongs
• 8.4. Flared Prongs
• 8.5. Straight Prongs

9. By Material

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 9.1.2. Market Attractiveness Index, By Material
• 9.2. PVC *
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 9.3. Silicone
• 9.4. Others

10. By Application

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.1.2. Market Attractiveness Index, By Application
• 10.2. Asthma *
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 10.3. COPD
• 10.4. Cystic Fibrosis
• 10.5. Sleep Apnea
• 10.6. Pneumonia
• 10.7. Cardiovascular Surgery
• 10.8. Diabetes Treatment
• 10.9. Others

11. By End-User

• 11.1. Introduction
  • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.1.2. Market Attractiveness Index, By End-User
• 11.2. Hospitals *
  • 11.2.1. Introduction
  • 11.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 11.3. Ambulatory Surgical Centers
• 11.4. Neonatal Intensive Care Units
• 11.5. Home Care Setting
• 11.6. Others

12. By Region

• 12.1. Introduction
  • 12.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 12.1.2. Market Attractiveness Index, By Region
• 12.2. North America
  • 12.2.1. Introduction
  • 12.2.2. Key Region-Specific Dynamics
  • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Prong Shape
  • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.2.8.1. U.S.
    • 12.2.8.2. Canada
    • 12.2.8.3. Mexico
• 12.3. Europe
  • 12.3.1. Introduction
  • 12.3.2. Key Region-Specific Dynamics
  • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Prong Shape
  • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.3.8.1. Germany
    • 12.3.8.2. U.K.
    • 12.3.8.3. France
    • 12.3.8.4. Italy
    • 12.3.8.5. Spain
    • 12.3.8.6. Rest of Europe
• 12.4. South America
  • 12.4.1. Introduction
  • 12.4.2. Key Region-Specific Dynamics
  • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Prong Shape
  • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.4.8.1. Brazil
    • 12.4.8.2. Argentina
    • 12.4.8.3. Rest of South America
• 12.5. Asia Pacific
  • 12.5.1. Introduction
  • 12.5.2. Key Region-Specific Dynamics
  • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Prong Shape
  • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.5.8.1. China
    • 12.5.8.2. India
    • 12.5.8.3. Japan
    • 12.5.8.4. Australia
    • 12.5.8.5. Rest of Asia Pacific
• 12.6. Middle East and Africa
  • 12.6.1. Introduction
  • 12.6.2. Key Region-Specific Dynamics
  • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Prong Shape
  • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

• 13.1. Key Developments and Strategies
• 13.2. Company Share Analysis
• 13.3. Products Benchmarking
• 13.4. List of Key Companies to Watch

14. Company Profiles

• 14.1. Smith's Medical (ICU Medical) *
  • 14.1.1. Company Overview
  • 14.1.2. Product Portfolio and Description
  • 14.1.3. Key Highlights
  • 14.1.4. Financial Overview
• 14.2. Teleflex Inc.
• 14.3. Medline Industries Inc.
• 14.4. Hamilton Medicals
• 14.5. Neotech Products
• 14.6. Medin Medical Innovations GmbH
• 14.7. Flexicare Ltd.
• 14.8. Fairmont Medical
• 14.9. Fisher & Paykel Healthcare Limited
• 14.10. Sunset Healthcare Solutions Inc.

LIST NOT EXHAUSTIVE

15. Global Nasal Cannula Market - DataM

• 15.1. Appendix
• 15.2. About Us and Application
• 15.3. Contact Us